Â鶹´«Ã½


News COVID Experts

Filters close

Showing results 1 – 1 of 1

access_time Embargo lifts in 2 days
Embargo will expire: 20-Feb-2025 11:00 AM EST Released to reporters: 19-Feb-2025 5:20 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 20-Feb-2025 11:00 AM EST The Â鶹´«Ã½ PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Â鶹´«Ã½: U.S. Facing Critical Hospital Bed Shortage by 2032
17-Feb-2025 4:25 PM EST
U.S. Facing Critical Hospital Bed Shortage by 2032
University of California, Los Angeles (UCLA), Health Sciences

The new post-pandemic national hospital occupancy average is 75% -- a full 11 percentage points higher than the pre-pandemic average, largely due to a reduction in staffed hospital beds. This puts the U.S. on track for a severe shortage of hospital beds by 2032 unless action is taken.

Released: 18-Feb-2025 8:00 PM EST
New Research From Northwestern Medicine Reveals Link Between Long COVID and Eye Health
Northwestern Medicine

New research from Northwestern Medicine reveals link between long COVID and eye health

Â鶹´«Ã½: Five Years After COVID-19 Shutdown, 20 MSU Experts Share
Lessons Learned, Lasting Impacts and Outlook
Released: 18-Feb-2025 9:10 AM EST
Five Years After COVID-19 Shutdown, 20 MSU Experts Share Lessons Learned, Lasting Impacts and Outlook
Michigan State University

Vaccines, work from home, online learning, curbside pickup and masks became part of the daily routine as states issued stay-home orders in March 2020 to reduce the spread of COVID-19.

Â鶹´«Ã½: Designing Antivirals for Shape-Shifting Viruses
12-Feb-2025 8:20 PM EST
Designing Antivirals for Shape-Shifting Viruses
Biophysical Society

Viruses, like those that cause COVID-19 or HIV, are formidable opponents once they invade our bodies. Antiviral treatments strive to block a virus or halt its replication. However, viruses are dynamic - constantly evolving and changing shape, which can make designing antiviral treatments a challenge.

Â鶹´«Ã½: Evolutionary Tradeoffs: Research Explores the Role of Iron Levels in COVID-19 Infections
Released: 13-Feb-2025 9:35 PM EST
Evolutionary Tradeoffs: Research Explores the Role of Iron Levels in COVID-19 Infections
Binghamton University, State University of New York

Our immune systems rely on iron to function, but so do invading viruses and bacteria. New research from Binghamton University, State Univerity of New York studying healthcare workers in Nigeria during COVID, reveals that very early in the arms race ¡ª when an infectious disease is emerging and still very new to humans ¡ª iron nutrition tradeoffs are in play.

Released: 5-Feb-2025 7:00 PM EST
Nasal COVID-19 Vaccine Based on WashU Technology to Enter U.S. Clinical Trials
Washington University in St. Louis

A nasal vaccine for COVID-19 ¨C based on technology developed at Washington University in St. Louis ¨C is poised to enter a phase 1 clinical trial in the U.S.

Released: 29-Jan-2025 6:10 PM EST
Four Advances for Inactivating Infectious Viruses, Bacteria
American Chemical Society (ACS)

It¡¯s peak cold and flu season in the northern hemisphere. Four papers published in ACS journals provide insights into novel antiviral compounds and methods to inactivate infectious viral particles and bacteria.

   

Showing results 1 – 1 of 1


close
2.30751